← Back to Patent Explorer
US4493910A Expired / Lapsed US ⏱️ 0.0 years remaining

Fluorine-containing hydrogel-forming polymeric materials

Assignee: Kelvin Lenses Ltd
•
Filing: 1983-06-24
•
Granted: 1985-01-15
•
Expires: 2003-06-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Polymeric materials suitable for bio-medical applications, particularly in making contact lenses, are derived by reaction of the following: (1) 20 to 40 mole % of a polymerizable amide which is an unsubstituted or substituted amide of a carboxylic acid containing olefinic unsaturation, (2) 25 to 55 mole % of an N-vinyl lactam, (3) 5 to 20 mole % of a polymerizable ester which is an ester of a carboxylic acid containing olefinic unsaturation, (4) 1 to 10 mole % of a polymerizable carboxylic acid containing olefinic unsaturation, and (5) 3 to 10 mole % of a hydrophobic monomer component comprising: (a) a fluorine-containing polymerizable monomer having a fluoroaliphatic side chain, or a polymerizable monomer having an esterifiable group, and (b) a non-fluorine-containing polymerizable hydrophobic vinyl monomer; and subsequently esterifying any esterifiable groups provided by monomer (5a) using a fluorine-containing aliphatic acid or derivative thereof, the amounts of the monomers (1) to (5) totalling 100 mole %, and either the copolymerization is carried out in the presence of a cross linking agent or the resulting copolymer is subsequently cross linked. The polymeric material of the present invention may be machined to form contact lenses and subsequently hydrated to form a hydrogel which is suitable for use as an extended wear contact lens.

Inventors

  • 👤 Brian J. Tighe
  • 👤 Howard J. Gee

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 20:10
CPC Classifications
G; G02; G02B; G02B1/00; G02B1/04; G02B1/041; G02B1/043; C; C08; C08F; C08F220/00; C08F220/02; C08F220/52; C08F220/54; C08F226/00; C08F226/06; C08F8/00; C08F8/18; C08F8/20

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 303 words
A contact lens consisting essentially of a copolymer and at least 63% by weight water wherein the copolymer is a crosslinked fluorine-containing polymeric material suitable for use in biomedical applications, containing units derived either by simultaneous copolymerisation and crosslinking or by copolymerisation and subsequent crosslinking of the following monomers: (1) to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types a) and b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, carboxylic acid or ester or a non-fluorine-containing unsaturated alcohol which, after copolymerisation of monomer (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof; and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, the crosslinking having been effected with crosslinking amounts of a crosslinking agent, which, in the case of simultaneous copolymerisation and crosslinking, is an ester of a diol and acrylic or methacrylic acid or is divinylbenzene, or, in the case of crosslinking subsequent to copolymerisation, is a latent crosslinking agent which is a diamide of an unsaturated aliphatic carboxylic acid, an anhydride of an aliphatic or aromatic carboxylic acid, a diepoxide or dicumyl peroxide, the crosslinking agent having been used in an amount of up to 5 weight % based on the total weight of monomers (1) to (5).
Claim 2
Dependent Claim 303 words
A contact lens consisting essentially of a copolymer and at least 63% by weight water wherein the copolymer is a crosslinked fluorine-containing polymeric material suitable for use in biomedical applications, containing units derived either by simultaneous copolymerisation and crosslinking or by copolymerisation and subsequent crosslinking of the following monomers: (1) to 40 mole % of an amide of acrylic or methacrylic acid; (2) 25 to 55 mole % of an N-vinyl lactam of the N-vinyl pyrrolidone type; (3) 5 to 20 mole % of a hydroxyalkyl ester of acrylic or methacrylic acid; (4) 1 to 10 mole % of acrylic or methacrylic acid; and (5) at least about 5 up to about 10 mole % of a hydrophobic monomer component comprising two monomer types a) and b) as follows: (a) a fluorine-containing olefine, or fluorine-containing unsaturated alcohol, carboxylic acid or ester or a non-fluorine-containing unsaturated alcohol which, after copolymerisation of monomer (1) to (5), is esterified using a fluorine-containing aliphatic carboxylic acid or derivative thereof; and (b) a non-fluorine-containing polymerisable hydrophobic vinyl monomer which is at least one monomer selected from vinyl aromatic hydrocarbons of the styrene type and hydrophobic esters of acrylic or methacrylic acid; the monomers (1) to (5) totalling 100 mole %, the crosslinking having been effected with crosslinking amounts of a crosslinking agent, which, in the case of simultaneous copolymerisation and crosslinking, is an ester of a diol and acrylic or methacrylic acid or is divinylbenzene, or, in the case of crosslinking subsequent to copolymerisation, is a latent crosslinking agent which is a diamide of an unsaturated aliphatic carboxylic acid, an anhydride of an aliphatic or aromatic carboxylic acid, a diepoxide or dicumyl peroxide, the crosslinking agent having been used in an amount of up to 5 weight % based on the total weight of monomers (1) to (5).
Claim 3
Dependent Claim 13 words
A lens according to claim 1 wherein component 5a comprises a fluoroalkyl group.
Claim 4
Dependent Claim 16 words
A lens according to claim 2 wherein the fluoroalkyl group contains 1 to 12 carbon atoms.
Claim 5
Dependent Claim 14 words
A lens according to claim 1 wherein component 5a comprises a terminal trifluoromethyl group.
Claim 6
Dependent Claim 33 words
A lens according to claim 1 wherein component 5a comprises a fluoro-substituted aliphatic ester group of the general formula: ##STR4## where X represents a fluoro-substituted alkyl group containing up to 6 carbon atoms.
Claim 7
Dependent Claim 50 words
A lens according to claim 1 wherein component 5a is trifluoroethyl acrylate or methacrylate, hexafluoroisopropyl acrylate or methacrylate, 1,1,3-trihydroperfluoropropyl methacrylate, a perfluoroalkyl alkyl methacrylate of formula: ##STR5## or a fluoro-alcohol methacrylate of formula: ##STR6## wherein m and n are integers such that the compounds contain up to 12 carbon atoms.
Claim 8
Dependent Claim 18 words
A lens according to claim 1 containing units derived from 1 to 9 mole % of component 5a.
Claim 9
Dependent Claim 24 words
A lens according to claim 1 wherein component (1) is acrylamide, methacrylamide or diacetone acrylamide or a mixture of two or all of these.
Claim 10
Dependent Claim 11 words
A lens according to claim 1 wherein component (2) is N-vinylpyrrolid-2-one.
Claim 11
Dependent Claim 15 words
A lens according to claim 1 wherein component (3) is hydroxypropyl acrylate or hydroxyethyl methacrylate.
Claim 12
Dependent Claim 22 words
A lens according to claim 1 wherein component 5b is styrene, an ester of acrylic or methacrylic acid or a mixture thereof.
Claim 13
Dependent Claim 29 words
A lens according to claim 1 wherein the crosslinking agent in the case of simultaneous copolymerisation and crosslinking is ethylene glycol dimethacrylate, a polyethylene oxide dimethacrylate or divinyl benzene.
Claim 14
Dependent Claim 59 words
A process for preparing a contact lens which comprises forming a crosslinked copolymer as defined in claim 1 in a mould, cutting and shaping the moulded copolymer to form a contact lens which can subsequently be converted into a hydrogel containing at least 63% by weight water by immersion in water or an aqueous medium until equilibrium is reached.

References Cited (Backward Citations)

US3658857A Cited
FR2091417A5 Cited
GB1566249A Cited
EP0017512A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-01-15 1988-07-16 1989-01-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-01-15 1992-07-16 1993-01-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-01-15 1996-07-16 1997-01-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag